GL1X · GenesisL1 explorer

Research workbench

Crystal structure of HCV NS5B RNA polymerase complexed with a novel non-competitive inhibitor.

Analyse Crystal structure of HCV NS5B RNA polymerase complexed with a novel… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1OS5
Type
protein
Length
563 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hepatitis C virus NS5B RNA polymerase
UniProt
P26663
Ligands
NH1
Pockets
6 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHepatitis C virus NS5B RNA polymeraseprotein56349% helix, 15% strandP26663

Ligands and binding sites

  • NH1 · 3-(4-amino-2-tert-butyl-5-methyl-phenylsulfanyl)-6-cyclopentyl-4-hydroxy-6-[2-(4-hydroxy-phenyl)-ethyl]-5,6-dihydro-pyran-2-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110560.790.8186empty
21110.450.7818empty
31330.430.7520NH1
41010.400.7623empty
51080.380.7523empty

Compared structures

  • 1OS5 · Crystal structure of HCV NS5B RNA polymerase complexed with a novel non-competitive… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.